No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs189340507 |
chr8:20907316-20907317 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs192595386 |
chr8:20907381-20907382 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs541024995 |
chr8:20907426-20907427 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs553308451 |
chr8:20907427-20907428 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs116704108 |
chr8:20907428-20907429 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs544893710 |
chr8:20907462-20907463 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs183715839 |
chr8:20907463-20907464 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs530601174 |
chr8:20907464-20907465 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs58110635 |
chr8:20907465-20907466 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs560173076 |
chr8:20907487-20907488 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs561042166 |
chr8:20907504-20907505 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs148549187 |
chr8:20907538-20907539 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs546547795 |
chr8:20907547-20907548 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs34527344 |
chr8:20907550-20907551 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs112321062 |
chr8:20907552-20907553 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs532811527 |
chr8:20907559-20907560 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs113181150 |
chr8:20907567-20907568 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs114215003 |
chr8:20907595-20907596 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs146568449 |
chr8:20907613-20907614 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs74830061 |
chr8:20907650-20907651 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs555549013 |
chr8:20907666-20907667 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs567324292 |
chr8:20907680-20907681 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs534612880 |
chr8:20907751-20907752 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs552972750 |
chr8:20907766-20907767 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs141304601 |
chr8:20907784-20907785 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs557517072 |
chr8:20907804-20907805 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs556963894 |
chr8:20907811-20907812 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs542086320 |
chr8:20907827-20907828 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs1546710 |
chr8:20907847-20907848 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
30 |
rs572780462 |
chr8:20907852-20907853 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs542409164 |
chr8:20907964-20907965 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs527912953 |
chr8:20907979-20907980 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs528530198 |
chr8:20908034-20908035 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs540252847 |
chr8:20908055-20908056 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs564966466 |
chr8:20908074-20908075 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs532388136 |
chr8:20908101-20908102 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs35517020 |
chr8:20908109-20908110 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs575620180 |
chr8:20908115-20908116 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs113481789 |
chr8:20908120-20908121 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs546070902 |
chr8:20908121-20908122 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs551298705 |
chr8:20908140-20908141 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs115413148 |
chr8:20908156-20908157 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs530319544 |
chr8:20908167-20908168 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs145071773 |
chr8:20908210-20908211 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs151242996 |
chr8:20908213-20908214 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs534681350 |
chr8:20908219-20908220 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs376685978 |
chr8:20908221-20908222 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs571258770 |
chr8:20908222-20908223 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs188433345 |
chr8:20908227-20908228 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs557223338 |
chr8:20908244-20908245 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|